Publikationen

Erst- / Letztautor:

  1. Beyerlein A., Fahrmeir L., Mansmann U., Toschke A. M.: Alternative regression models to assess increase in childhood BMI. BMC Med Res Methodol. 2008; 8:59.
  2. Beyerlein A., Toschke A. M., von Kries R.: Breastfeeding and childhood obesity: Shift of the entire BMI distribution or only the upper parts? Obesity 2008; 16(12):2730-3. IF 2.762.
  3. Beyerlein A., Schiessl B., Lack N., von Kries R.: Optimal gestational weight gain ranges for the avoidance of adverse birth weight outcomes – a novel approach. Am J Clin Nutr. 2009; 90(6):1552-8. IF 6.307.
  4. Beyerlein A., Hadders-Algra M., Kennedy K., Fewtrell M., Singhal A., Rosenfeld E., Lucas A., Bouwstra H., Koletzko B., von Kries R.: Infant formula supplementation with long-chain polyunsaturated fatty acids has no effect on Bayley Developmental Scores at 18 months of age – IPD meta-analysis of 4 large clinical trials. J Pediatr Gastr Nutr. 2010; 50(1):79-84. IF 2.180.
  5. Beyerlein A., Toschke A. M., von Kries R.: Risk factors for childhood overweight: shift of the mean body mass index and shift of the upper percentiles: results from a cross-sectional study. Int J Obes (Lond). 2010; 34(4):642-8. IF 5.125.
  6. Beyerlein A., Ness A. R., Streuling I., Hadders-Algra M., von Kries R.: Early rapid growth: no association with later cognitive functions in children born not small for gestational age. Am J Clin Nutr. 2010; 92(3):585-93. IF 6.606.
  7. Beyerlein A., Lack N., von Kries R.: Within-Population–Average Ranges Compared With Institute of Medicine Recommendations for Gestational Weight Gain. Obstet Gynecol. 2010; 116(5):1111-8. IF 4.392.
  8. Beyerlein A., von Kries R., Hummel M., Lack N., Schiessl B., Giani G., Icks A.: Improvement in pregnancy-related outcomes in the offspring of diabetic mothers in Bavaria, Germany, during 1987 to 2007. Diabet Med. 2010; 27(12):1379-84. IF 3.036.
  9. Beyerlein A., Schiessl B., Lack N., von Kries R: Associations of gestational weight loss with birth-related outcomes: a retrospective cohort study. BJOG. 2011; 118(3):278-84. IF 3.407.
  10. Beyerlein A., Toschke A. M., Schaffrath Rosario A., von Kries R.: Risk Factors for Obesity: Further Evidence for Stronger Effects on Overweight Children and Adolescents Compared to Normal-Weight Subjects. PLoS One. 2011;6(1):e15739. IF 4.092.
  11. Beyerlein A., Rückinger S., Toschke A. M., Schaffrath Rosario A., von Kries R.: Is low birth weight in the causal pathway of the association between maternal smoking in pregnancy and higher BMI in the offspring? Eur J Epidemiol. 2011; 26(5):413-20. IF 4.713.
  12. Beyerlein A., von Kries R.: Breastfeeding and body composition in children: will there ever be conclusive empirical evidence for a protective effect against overweight? Am J Clin Nutr. 2011; 94(6 Suppl):1772S-1775S. IF 6.669.
  13. Beyerlein A., von Kries R., Ness A. R., Ong K. K.: Genetic markers of obesity risk: Stronger associations with body composition in overweight compared to normal-weight children. PLoS One. 2011; 6(4):e19057. IF 4.092.
  14. Beyerlein A., Nehring I., Schaffrath Rosario A., von Kries R.: Gestational diabetes and cardiovascular risk factors in the offspring: Results from a cross-sectional study. Diabet Med. 2012; 29(3):378-84. IF 3.241.
  15. Thummerer Y., von Kries R., Marton A. M., Beyerlein A.: Is age or speed the predominant factor in the development of trunk movement in normally developing children? Gait Posture. 2012; 35(1):23-8. IF 1.969.
  16. Beyerlein A., Nehring I., Rzehak P., Heinrich J., Müller M. J., Plachta-Danielzik S., Wabitsch M., Weck M., Brenner H., Rothenbacher D., von Kries R.: Gestational weight gain and body mass index in children: Results from three German cohort studies. PLoS One. 2012; 7(3): e33205. IF 3.730.
  17. Riedel C., von Kries R., Fenske N., Strauch K., Ness A. R., Beyerlein A.: Interactions of genetic and environmental risk factors with respect to body fat mass in children: Results from the ALSPAC study. Obesity 2013; 21: 1238-42. IF 4.389.
  18. Beyerlein A., Wehweck F., Ziegler A.-G., Pflueger M.: Respiratory Infections in Early Life and the Development of Islet Autoimmunity in Children at Increased Type 1 Diabetes Risk: Evidence From the BABYDIET Study. JAMA Pediatr 2013; 167(9): 800-7. IF 4.282.
  19. Warncke K., Krasmann M., Puff R., Dunstheimer D., Ziegler A.-G., Beyerlein A.: Does Diabetes Appear in Distinct Phenotypes in Young People? Results of the Diabetes Mellitus Incidence Cohort Registry (DiMelli). PLoS One 2013; 8(9): e74339. IF 3.534.
  20. Hummel S., Much D., Rossbauer M., Ziegler A.-G., Beyerlein A.: Postpartum Outcomes in Women with Gestational Diabetes and their Offspring: POGO Study Design and First-Year Results. Rev Diabet Stud 2013; 10:49-57. IF 2.135.
  21. Beyerlein A., Kusian D., Ziegler A.-G., Schaffrath-Rosario A., von Kries R.: Classification tree analyses reveal limited potential for early targeted prevention against childhood overweight. Obesity 2014; 22(2): 512-7. IF 3.734.
  22. Beyerlein A., Thiering E., Pflueger M., Bidlingmaier M., Stock J., Knopff A., Winkler C.,  Heinrich J., Ziegler A.-G.: Early infant growth is associated with the risk of islet autoimmunity in genetically susceptible children. Pediatr Diabetes 2014; 15(7):534-42. IF 2.569.
  23. Beyerlein A., Chmiel R., Hummel S., Winkler C., Bonifacio E., Ziegler A.-G.: Timing of gluten introduction and islet autoimmunity in young children: Updated results from the BABYDIET study. Diabetes Care 2014; 37(9):e194-5. IF 8.420.
  24. Beyerlein A.: Quantile regression – opportunities and challenges from a user’s perspective. Am J Epidemiol 2014; 180(3):330-1. IF 5.230.
  25. Beyerlein A., Krasmann M., Thiering E., Kusian D., Markevych I., D’Orlando O., Warncke K., Jochner S., Heinrich J., Ziegler A.-G.: Ambient air pollution and early manifestation of type 1 diabetes. Epidemiology 2015; 26(3):e31-2. IF 6.075.
  26. Beyerlein A., Liu X., Uusitalo U. M., Harsunen M., Norris J. M., Foterek K., Virtanen S. M., Rewers M. J., She J.-X., Simell O., Lernmark Å., Hagopian W., Akolkar B., Ziegler A.-G., Krischer J. P., Hummel S., and the TEDDY study group: Dietary intake of soluble fiber and risk of islet autoimmunity by 5 y of age: results from the TEDDY study. Am J Clin Nutr 2015; 102(2):345-52. IF 6.703.
  27. Köhler M., Ziegler A.-G., Beyerlein A.: Development of a simple tool to predict the risk of postpartum diabetes in women with gestational diabetes mellitus. Acta Diabetol 2016; 53(3):433-7. IF 3.340.
  28. Much D., Jaschinski H., Lack N., Hummel S., Füchtenbusch M., Hummel M., Ziegler A.-G., Beyerlein A.: Risk stratification in women with gestational diabetes according to and beyond current WHO criteria. Horm Metab Res. 2016; 48(1):16-9. IF 2.268.
  29. Beyerlein A., Markevych I., Thiering E., Warncke K., Heinrich J., Ziegler A.-G.: Response to: Ambient Air Pollution is not Associated with Early Manifestation of Type 1 Diabetes. Epidemiology 2016; 27(4):e26-e28.
  30. Beyerlein A., Donnachie E., Jergens S., Ziegler A.-G.: Infections in early life and development of type 1 diabetes. JAMA 2016; 315(17):1899-901. IF 44.405.
  31. Beyerlein A., Donnachie E., Ziegler A.-G.: Association of infection in early life and risk of developing type 1 diabetes – Reply. JAMA 2016; 316(8):883.
  32. Beyerlein A., Koller D., Ziegler A.-G., Lack N., Maier W.: Does charge-free screening improve detection of gestational diabetes in women from deprived areas: a cross-sectional study. BMC Pregnancy Childbirth 2016; 16:266. IF 2.263.
  33. Beyerlein A.: Können Infektionen das Diabetesrisiko erhöhen? Dtsch Arztebl. 2016; 113(43):14-16. IF 0.62.
  34. Yassouridis C., Leisch F., Winkler C., Ziegler A.-G., Beyerlein A.: Associations of growth patterns and islet autoimmunity in children with increased risk for type 1 diabetes: a functional analysis approach. Pediatr Diabetes 2017; 18(2):103-110. IF 3.161.
  35. Hummel S.*, Beyerlein A.*, Tamura R., Uusitalo U., Aronsson C. A., Yang J., Riikonen A., Lernmark Å., Rewers M. J., Hagopian W. A., She J.-X., Simell O. G., Toppari J., Ziegler A.-G., Akolkar B., Krischer J. P., Virtanen S. M., Norris J. M., and the TEDDY study group: First infant formula type and risk of islet autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Care 2017; 40(3):398-404. IF 13.397. *shared first authorship
  36. Beyerlein A.*, Strobl A. N.*, Winkler C., Carpus M., Knopff A., Donnachie E., Ankerst D. P., Ziegler A.-G.: Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data. Vaccine 2017; 35(14):1735-1741. IF 3.285. *shared first authorship
  37. Beyerlein A., Donnachie E., Ziegler A.-G.: Infections in early life and development of celiac disease. Am J Epidemiol 2017; 186(11):1277-1280. IF 4.322.
  38. Beyerlein A., Uusitalo U. M., Virtanen S. M., Vehik K., Yang J., Winkler C., Kersting M., Koletzko S., Schatz D., Aronsson C. A., Elding Larsson H., Krischer J. P., Ziegler A.-G., Norris J. M., Hummel S., and the TEDDY study group: Intake of energy and protein is associated with overweight risk at age 5.5 years: Results from the prospective TEDDY study. Obesity 2017; 25(8):1435-1441. IF 4.042.
  39. Köhler M.*, Beyerlein A.*, Vehik K., Greven S., Umlauf N.,  Lernmark Å., Hagopian W. A., Rewers M., She J.-X., Toppari J., Akolkar B., Krischer J. P., Bonifacio E., Ziegler A.-G., TEDDY study group: Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: results from the TEDDY study. Acta Diabetol 2017; 54(11):1009-1017. IF 3.126. *shared first authorship
  40. Warncke K., Lickert R., Eitel S., Gloning K.-P., Bonifacio E., Sedlmeier E.-M., Becker P., Knoop J., Beyerlein A.*, Ziegler A.-G.*  Thymus growth and fetal immune responses in diabetic pregnancies. Horm Metab Res 2017; 49(11):892-898. IF 2.560. *shared last authorship
  41. Beyerlein A., Lack N., von Kries R.: No further improvement in pregnancy-related outcomes in the offspring of mothers with pre-gestational diabetes in Bavaria, Germany, between 2001 and 2016. Diabet Med 2018; 35(10):1420-1424. IF 3.107.
  42. Pitchika A., Jolink M., Winkler C., Hummel S., Hummel N., Krumsiek J., Kastenmüller G., Raab J., Kordonouri O., Ziegler A.-G.*, Beyerlein A.*: Associations of maternal type 1 diabetes with childhood adiposity and metabolic health in the offspring: prospective cohort study. Diabetologia 2018; 61(11):2319-2332. IF 7.113. *shared last authorship
  43. Heinrich M., Maison N., Achenbach P., Assfalg R., Braig S., Böcker D., Dunstheimer D., Ermer U., Gavazzeni A., Gerstl E. M., Hummel S., Kick K., Müller H., Nellen-Hellmuth N., Ockert C., Sindichakis M., Tretter S., Warncke K., Ziegler A.-G.*, Beyerlein A.*; and the Fr1da-Study group: Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetes. Pediatric Diabetes 2018; 19(7):1238-1242. IF 3.347. *shared last authorship
  44. Pitchika A., Vehik K., Hummel S., Norris J. M., Uusitalo U. M., Yang J., Virtanen S. M., Koletzko S., Aronsson C. A., Ziegler A.-G.*, Beyerlein A.*, TEDDY Study Group: Associations of maternal diabetes during pregnancy with overweight in the offspring – Results from the prospective TEDDY study. Obesity 2018; 26:1457-1466. IF 3.969.*shared last authorship
  45. Ungethüm K., Jolink M., Hippich M., Lachmann L., Haupt F., Winkler C., Hummel S.,  Pitchika A., Kordonouri O., Ziegler A.-G.*, Beyerlein A.*: Physical Activity is Associated with Lower Insulin and C-peptide during Glucose Challenge in Children and Adolescents with Family Background of Diabetes. Diabet Med 2019; 36(3):366-375. IF 3.107. *shared last authorship
  46. Beyerlein A., Bonifacio E., Vehik K., Hippich M., Winkler C., Frohnert B. I., Steck A. K., Hagopian W. A., Krischer J. P., Lernmark Å., Rewers M. J., She J.-X., Toppari J., Akolkar B., Rich S. S., Ziegler A.-G., TEDDY Study Group: Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors – results from the prospective TEDDY study. J Med Gen 2019; 56(9):602-605. IF 5.899.
  47. Beyerlein A., Lack N., Maier W.: Associations of area-level deprivation with adverse obstetric and perinatal outcomes in Bavaria, Germany: Results from a cross-sectional study. PLoS One. 2020; 15(7):e0236020. IF 2.776.
  48. Gomes D.*, Beyerlein A.*, Katz K., Hoelscher G., Nennstiel U., Liebl B., Überla K., von Kries R.: Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany. PLoS One. 2021; 16(11):e0259370. IF 3.240. *shared first authorship. 
  49. Gleich S., Peschel O., Graw M., Beyerlein A.: Welche Auswirkungen zeigen unterschiedliche Sterbeorte betagter Menschen? Rechtsmedizin 2022, published ahead of print. IF 1.112.

Koautor:

  1. Toschke A. M., Beyerlein A., von Kries R.: Children at high risk for overweight: a classification and regression trees analysis approach. Obes Res. 2005; 13(7):1270-4. IF 3.701.
  2. Toschke A. M., von Kries R., Beyerlein A., Rückinger S.: Risk factors for childhood overweight: Shift of the entire BMI distribution vs. shift of the upper tail only in a cross sectional study. BMC Public Health. 2008; 8:115. IF 2.029.
  3. Rosenfeld E., Beyerlein A., Hadders-Algra M., Kennedy K., Singhal A., Fewtrell M., Lucas A., Koletzko B., von Kries R.: IPD meta-analysis shows no effect of LC-PUFA supplementation on infant growth at 18 months. Acta Paediatr. 2009;98(1):91-7. IF 1.768.
  4. Schiessl B., Beyerlein A., Lack N., von Kries R.: Temporal trends in pregnancy weight gain and birth weight in Bavaria 2000-2007: slightly decreasing birth weight with increasing weight gain in pregnancy. J Perinat Med. 2009; 37(4):374-9. IF 1.736.
  5. Streuling I., Beyerlein A., von Kries R.: Can gestational weight gain be modified by increasing physical activity and diet counselling? A meta-analysis of interventional trials. Am J Clin Nutr. 2010; 92(4):678-87. IF 6.606.
  6. Rückinger S., Beyerlein A., Jacobsen G., von Kries R., Vik T.: Growth in utero and body mass index at age 5 years in children of smoking and non-smoking mothers. Early Hum Dev. 2010; 86(12):773-7. IF 1.587.
  7. von Kries R., Ensenauer R., Beyerlein A., Amann-Gassner U., Hauner H., Schaffrath Rosario A.: Gestational weight gain and overweight in children: Results from the cross-sectional German KiGGS study. Int J Pediatr Obes. 2011; 6:45-52. IF 2.986.
  8. Streuling I., Beyerlein A., Rosenfeld E., Schukat B., von Kries R.: Weight gain and dietary intake in industrialized countries – a systematic review of observational studies. J Perinat Med. 2011; 39(2):123-9. IF 1.702.
  9. Streuling I., Beyerlein A., Rosenfeld E., Hofmann H., Schulz T., von Kries R.: Physical activity and gestational weight gain: A meta-analysis of intervention trials. BJOG. 2011; 118(3):278-84. IF 3.407.
  10. Dalla Pozza R., Beyerlein A., Thilmany C., Weissenbacher C., Netz H., Schmidt H., Bechtold S.: The effect of body mass index and blood pressure on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol. 2011; 10:53. IF 3.346.
  11. Nehring I., Schmoll S., Beyerlein A., Hauner H., von Kries R.: Gestational weight gain and long-term postpartum weight retention: a meta-analysis. Am J Clin Nutr. 2011; 94(5):1225-31. IF 6.669.
  12. von Kries R., Beyerlein A., Müller M. J., Heinrich J., Landsberg B., Bolte G., Chmitorz A., Plachta-Danielzik S.: Different age-specific incidence and remission rates in pre-school and primary school suggest need for targeted obesity prevention in childhood. Int J Obes (Lond). 2012; 36(4):505-10. IF 5.221.
  13. Bechtold S., Beyerlein A., Ripperger P., Roeb J., Dalla Pozza R., Häfner R., Haas J. P., Schmidt H.: Total pubertal growth in patients with juvenile idiopathic arthritis treated with growth hormone: Analysis of a single center. Growth Horm IGF Res. 2012; 22(5):180-5. IF 2.256.
  14. Göbel U., von Kries R., Teske C., Schneider D. T., Beyerlein A., Bernbeck B., Calaminus G.: Brain metastases during follow-up of children and adolescents with extracranial malignant germ cell tumors: Risk adapted management decision tree analysis based on data of the MAHO/MAKEI-registry. Pediatr Blood Cancer. 2013; 60(2):217-23. IF 2.562.
  15. Harsunen M. H., Puff R., D’Orlando O., Giannopoulou E., Lachmann L., Beyerlein A., von Meyer A., Ziegler A. G.: Reduced blood leukocyte and neutrophil numbers in the pathogenesis of type 1 diabetes. Horm Metab Res. 2013; 45(6):467-70. IF 2.038.
  16. Krause S., Beyerlein A., Winkler C., Gavrisan A., Kayser C., Puff R., Bonifacio E., Ziegler A. G., Achenbach P.: Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes. Acta Diabetol. 2014; 51(3):517-8. IF 2.399.
  17. Giannopoulou E. Z., Puff R., Beyerlein A., von Luettichau I., Boerschmann H., Schatz D., Atkinson M., Haller M. J.,  Egger D.,  Burdach S., Ziegler A. G.: Effect of a single autologous cord blood infusion on beta cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial. Pediatr Diabetes 2014; 15(2):100-9. IF 2.569.
  18. Stumpp C., Beyerlein A., Ziegler A.-G., Bonifacio E.: Neonatal and infant beta cell hormone concentrations in relation to type 1 diabetes risk. Pediatr Diabetes 2014; 15(7):528-33. IF 2.569.
  19. Much D., Beyerlein A., Roßbauer M., Hummel S., Ziegler A.-G.: Beneficial effects of breastfeeding in women with gestational diabetes mellitus. Mol Metab. 2014; 3(3):284-292.
  20. Ferreira R., Guo H., Coulson R., Smith D., Pekalski M., Burren O., Cutler A., Doecke J., Flint S., McKinney E., Lyons P., Smith K., Achenbach P., Beyerlein A., Dunger D., Wicker L., Todd J., Bonifacio E., Wallace C., Ziegler A.-G.: A type I interferon transcriptional signature precedes autoimmunity in children genetically at-risk of type 1 diabetes. Diabetes 2014; 63(7):2538-50. IF 8.095.
  21. Jung N. H., Brix O., Bernius P., Schroeder A. S., Kluger G., Beyerlein A., Weir S., von Kries R., Narayanan U. G., Mall V., Berweck S.: German translation of the Caregiver Priorities and Child Health Index of Life with Disabilities questionnaire: test–rest reliability and correlation with gross motor function in children with cerebral palsy. Neuropediatrics 2014; 45(5):289-93. IF 1.291.
  22. Achenbach P., Winkler C., Haupt F., Beyerlein A., Ziegler A.-G.: Prädisposition, frühe Stadien und Phänotypen des Typ-1-Diabetes. Dtsch Med Wochenschr. 2014; 139(21):1100-4. IF 0.542.
  23. Jung N. H., Pereira B., Nehring I., Brix O., Bernius P., Schroeder S. A., Kluger G. J., Koehler T., Beyerlein A., Weir S., von Kries R., Narayanan U. G., Berweck S., Mall V.: Does hip displacement influence health-related quality of life in children with cerebral palsy? Dev Neurorehabil. 2014; 17(6):420-5. IF 2.050.
  24. Bechtold S., Beyerlein A., Bonfig W., Dalla Pozza R., Putzker S., Otto R., Schmidt H., Schwarz H.P.: Sexual Difference in Bone Geometry of Adult Patients with Classical Congenital Adrenal Hyperplasia: Data Using Peripheral Quantitative Computed Tomography. Horm Res Paediatr. 2014; 82(3):171-8. IF 1.573.
  25. Chmiel R., Beyerlein A., Knopff A., Hummel S., Ziegler A.-G., Winkler C.: Early Infant Feeding and Risk of Developing Islet Autoimmunity and Type 1 Diabetes. Acta Diabetol 2015; 52(3):621-4. IF 3.074.
  26. Puff R., D‘Orlando O., Heninger A. K., Kühn D., Krause S., Winkler C., Beyerlein A., Bonifacio E., Ziegler A.-G.: Compromised immune response in infants at risk for type 1 diabetes born by Caesarean Section. Clin Immunol. 2015; 160(2):282-5. IF 4.034.
  27. Giannopoulou E. Z., Winkler C., Chmiel R. Matzke C., Scholz M., Beyerlein A., Achenbach P., Bonifacio E., Ziegler A.-G.: Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 2015; 58(10):2317-2. IF 6.206.
  28. Raab J., Haupt F., Scholz M., Matzke C., Warncke K., Lange K., Assfalg R., Weininger K., Wittich S., Löbner S., Beyerlein A., Nennstiel-Ratzel U., Lang M., Laub O., Dunstheimer D., Bonifacio E., Achenbach P., Winker C., Ziegler A.-G., Fr1da Study Group: Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: Design and initial results of the Fr1da Study. BMJ Open 2016; 6(5):e011144. IF 2.369.
  29. Dalla Pozza R., Pirzer R., Beyerlein A., Weberruß H., Oberhoffer R., Schmidt-Trucksäss A., Netz H., Haas N.: Beyond intima-media-thickness: Analysis of the carotid intima-media-roughness in a paediatric population. Atherosclerosis 2016; 251:164-169. IF 4.239.
  30. Much D., Beyerlein A., Kindt A., Krumsiek J., Stückler F., Rossbauer M., Hofelich A., Wiesenäcker D., Hivner S., Herbst M., Römisch-Margl W., Prehn C., Adamski J., Kastenmüller G., Theis F., Ziegler A.-G., Hummel S.: Lactation is Associated with Altered Metabolomic Signatures in Women with Gestational Diabetes. Diabetologia 2016; 59(10):2193-202. IF 6.080.
  31. Ziegler A.-G., Haupt F., Scholz, M., Weininger K., Wittich S., Löbner S., Matzke C., Gezginci C., Riethausen S., Beyerlein A., Zillmer S., Amoroso M., Coles R., Powell M., Furmaniak J., Rees Smith B., Winkler C., Bonifacio E., Achenbach P.: 3 Screen ELISA for high throughput detection of beta cl autoantibodies in capillary blood. Diabetes Technol Ther 2016; 18(11):687-693. IF 2.698.
  32. Ashton M. P., Eugster A., Walther D., Daehling N., Riethausen S., Kuehn D., Klingel K., Beyerlein A., Zillmer S., Ziegler A.-G., Bonifacio E.: Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin. Sci Rep 2016; 6:32899. IF 4.259.
  33. von Toerne C., Laimighofer M., Achenbach P., Beyerlein A., de las Heras Gala T., Krumsiek J., Theis F. J., Ziegler A.-G., Hauck S. M.: Peptide serum markers in islet autoantibody-positive children. Diabetologia 2017; 60(2):287-295. IF 6.023.
  34. Heninger A.-K., Eugster A., Kuehn D., Buettner F., Kuhn M., Lindner A., Dietz S., Jergens S., Wilhelm C., Beyerlein A., Ziegler A.-G., Bonifacio E.: A Divergent Population of Pre-TH1/TH17/TFH-Like Autoantigen-Responsive CD4+ T Cells in Infants Prior to β Cell Autoimmunity. Sci Transl Med 2017; 9(378). IF 16.710.
  35. Köhler M., Umlauf N., Beyerlein A., Winkler C., Ziegler A.-G., Greven S.: Flexible Bayesian additive joint models with an application to type 1 diabetes research. Biom J 2017; 54(11):1009-1017. IF 1.114.
  36. Heussinger N., Della Marina A., Beyerlein A., Leiendecker B., Hermann-Alves S., Dalla Pozza R., Klepper J.: 10 patients, 10 years – Long term follow-up of cardiovascular risk factors in Glut1 deficiency treated with ketogenic diet therapies: A prospective, multicenter case series. Clin Nutr 2018; 37(6 Pt A):2246-2251. IF 6.402.
  37. Koletzko S., Lee H.-S., Beyerlein A., Aronsson C. A., Hummel M., Liu E., Simell V., Kurppa K., Lernmark Å., Hagopian W., Rewers M., She J.-X., Simell O., Toppari J., Ziegler A.-G., Krischer J., Agardh D., TEDDY Study Group: Caesarean Section on The Risk of Celiac Disease in the Offspring: The Teddy Study. J Pediatr Gastroenterol Nutr. 2018; 66(3):417-424. IF 3.015.
  38. Hummel S., Beyerlein A., Pfirrmann M., Hofelich A., Much D., Hivner S., Bunk M., Herbst M., Peplow C., Walter M., Kohn D., Hummel N., Kratzsch J., Hummel M., Füchtenbusch M., Hasford J., Ziegler A.-G.; PINGUIN Study Group. Efficacy of vildagliptin for prevention of postpartum diabetes in women with a recent history of insulin-requiring gestational diabetes: A phase II, randomized, double-blind, placebo-controlled study. Mol Metab. 2018; 9:168-175. IF 6.181.
  39. Bonifacio E., Beyerlein A., Hippich M., Winkler C., Vehik K., Weedon M. N., Laimighofer M., Hattersley A. T., Krumsiek J., Frohnert B. I., Steck A. K., Hagopian W. A., Krischer J. P., Lernmark Å., Rewers M. J., She J.-X., Toppari J., Akolkar B., Oram R. A., Rich S. S., Ziegler A.-G.; TEDDY Study Group: Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children. PLoS Med. 2018; 15(4):e1002548. IF 11.048.
  40. Peplow C., Assfalg R., Beyerlein A., Hasford J., Bonifacio E., Ziegler A.-G.: Blood draws up to 3% of blood volume in clinical trials are safe in children. Acta Paediatr. 2019; 108:940–944. IF 2.265.
  41. Hippich M., Beyerlein A., Hagopian W. A., Krischer J. P., Vehik K., Knoop J., Winkler C., Toppari J., Lernmark Å., Rewers M. J., Steck A. K., She J. X., Akolkar B., Robertson C. C., Onengut-Gumuscu S., Rich S. S., Bonifacio E., Ziegler A.-G.; TEDDY Study Group: Genetic Contribution to the Divergence in Type 1 Diabetes Risk Between Children From the General Population and Children From Affected Families. Diabetes 2019; 68(4):847-857. IF 7.199.
  42. Miller M., Sabrautzki S., Beyerlein A., Brielmeier M.: Combining fish and environmental PCR for diagnostics of diseased laboratory zebrafish in recirculating systems. PLoS One 2019; 14(9):e0222360. IF 2.776.
  43. Johnson R. K., Vanderlinden L., DeFelice B. C., Kechris K., Uusitalo U., Fiehn O., Sontag M., Crume T., Beyerlein A., Lernmark Å., Toppari J., Ziegler A.-G., She J.-X., Hagopian W., Rewers M., Akolkar B., Krischer J., Virtanen S. M., Norris J. M., TEDDY Study Group: Metabolite-related dietary patterns and the development of islet autoimmunity. Scientific Reports 2019; 15;9(1):14819. IF 4.011.
  44. Sorg A.-L., von Kries R., Klemme M., Gerstl L., Weinberger R., Beyerlein A., Lack N., Felderhoff-Müser U., Dzietko M.: Risk factors for perinatal arterial ischaemic stroke: a large case–control study. Dev Med Child Neurol 2020; 62(4):513-520. IF 3.532.
  45. Kunze S., Cecil A., Prehn C., Möller G., Ohlmann A., Wildner G., Thurau S., Unger K., Rößler U., Hölter S. M., Tapio S., Wagner F., Beyerlein A., Theis F., Zitzelsberger H., Kulka U., Adamski J., Graw J., Dalke C.: Posterior subcapsular cataracts are a late effect after acute exposure to 0.5 Gy ionizing radiation in mice. Int J Radiat Biol. 2021; 97(4):529-540. IF 2.368.
  46. Sorg A.-L., von Kries R., Klemme M., Gerstl L., Beyerlein A., Felderhoff-Müser U., Dzietko M.: Incidence and risk factors of cerebral sinovenous thrombosis in infants. Dev Med Child Neurol 2021; 63(6):697-704. IF 3.532.
  47. Hummel S., Weiss A., Bonifacio E., Agardh D., Akolkar B., Aronsson C. A., Hagopian W. A., Koletzko S., Krischer J. P., Lernmark Å., Lynch K., Norris J. M., Rewers M. J., She J.-X., Toppari J., Uusitalo U., Vehik K., Virtanen S. M., Beyerlein A., Ziegler A.-G., TEDDY Study Group: Associations of breastfeeding with childhood autoimmunity, allergies, and overweight: The TEDDY study. Am J Clin Nutr 2021; 114(1):134-142. IF 6.766.
  48. Sorg A.-L., Bergfeld L., Jank M., Corman V., Semmler I., Goertz A., Beyerlein A., Verjans E., Wagner N., Von Bernuth H., Lander F., Weil K., Hufnagel M., Spiekerkoetter U., Chao C.-M., Naehrlich L., Muntau A. C., Schulze-Sturm U., Hansen G., Wetzke M., Jung A.-M., Niehues T., Fricke-Otto S., Von Both U., Huebner J., Behrends U., Liese J. G., Schwerk C., Drosten C., Von Kries R., Schroten H.: Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021. Nat Commun 2022; 13(1):3128. IF 14.919.

Als Teil einer Study Group:

  1. Poston L., Harthoorn L. F., Van Der Beek E. M., Contributors to the ILSI Europe Workshop. Obesity in pregnancy: implications for the mother and lifelong health of the child. A consensus statement. Pediatr Res 2011; 69(2):175-80. IF 2.700.
  2. Aronsson C. A., Vehik K., Yang J., Uusitalo U., Hay K., Joslowski G., Riikonen A., Ballard L., Virtanen S. M., Norris J. M.; TEDDY Study Group: Use of dietary supplements in pregnant women in relation to sociodemographic factors – a report from The Environmental Determinants of Diabetes in the Young (TEDDY) study. Public Health Nutr. 2013; 16(8):1390-402. IF 2.483.
  3. Elding Larsson H., Vehik K., Gesualdo P., Akolkar B., Hagopian W., Krischer J., Lernmark Å., Rewers M., Simell O., She J. X., Ziegler A.-G., Haller M. J.; TEDDY Study Group: Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes. 2014; 15(2):118-26. IF 2.569.
  4. Lee H. S., Burkhardt B. R., McLeod W., Smith S., Eberhard C., Lynch K., Hadley D., Rewers M., Simell O., She J. X., Hagopian B., Lernmark A., Akolkar B., Ziegler A.-G., Krischer J. P.; TEDDY study group: Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Metab Res Rev. 2014;30(5):424-34. IF 3.553.
  5. Yang J., Lernmark Å., Uusitalo U. M., Lynch K. F., Veijola R., Winkler C., Larsson H. E., Rewers M., She J. X., Ziegler A.-G., Simell O. G., Hagopian W. A., Akolkar B., Krischer J. P., Vehik K.; TEDDY Study Group: Prevalence of obesity was related to HLA-DQ in 2-4-year-old children at genetic risk for type 1 diabetes. Int J Obes (Lond). 2014; 38(12):1491-6. IF 5.004.
  6. Liu E., Lee H. S., Aronsson C. A., Hagopian W. A., Koletzko S., Rewers M. J., Eisenbarth G. S., Bingley P. J., Bonifacio E., Simell V., Agardh D.; TEDDY Study Group: Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med. 2014; 371(1):42-9. IF 55.873.
  7. Törn C., Hadley D., Lee H. S., Hagopian W., Lernmark Å., Simell O., Rewers M., Ziegler A., Schatz D., Akolkar B., Onengut-Gumuscu S., Chen W. M., Toppari J., Mykkänen J., Ilonen J., Rich S. S., She J. X., Steck A. K., Krischer J.; TEDDY Study Group: Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study. Diabetes. 2015; 64(5):1818-29. IF 8.784.
  8. Kemppainen K. M., Ardissone A. N., Davis-Richardson A. G., Fagen J. R., Gano K. A., León-Novelo L. G., Vehik K., Casella G., Simell O., Ziegler A.-G., Rewers M. J., Lernmark Å., Hagopian W., She J. X., Krischer J. P., Akolkar B., Schatz D. A., Atkinson M. A., Triplett E. W.; TEDDY Study Group: Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care. 2015; 38(2):329-32. IF 8.934.
  9. Aronsson C. A., Lee H. S., Liu E., Uusitalo U., Hummel S., Yang J., Hummel M., Rewers M., She J. X., Simell O., Toppari J., Ziegler A.-G., Krischer J., Virtanen S. M., Norris J. M., Agardh D.; TEDDY Study Group: Age at gluten introduction and risk of celiac disease. Pediatrics. 2015; 135(2):239-45. IF 5.196.
  10. Steck A. K., Vehik K., Bonifacio E., Lernmark A., Ziegler A.-G., Hagopian W. A., She J., Simell O., Akolkar B., Krischer J., Schatz D., Rewers M. J.; TEDDY Study Group: Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care. 2015; 38(5):808-13. IF 8.934.
  11. Agardh D., Lee H. S., Kurppa K., Simell V., Aronsson C. A., Jörneus O., Hummel M., Liu E., Koletzko S.; TEDDY Study Group: Clinical features of celiac disease: a prospective birth cohort. Pediatrics. 2015; 135(4):627-34. IF 5.196.
  12. Lönnrot M., Lynch K., Larsson H. E., Lernmark Å., Rewers M., Hagopian W., She J. X., Simell O., Ziegler A.-G., Akolkar B., Krischer J., Hyöty H.; TEDDY Study Group: A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY. BMC Pediatr. 2015; 15:24. IF 1.904.
  13. Aronsson C. A., Lee H. S., Koletzko S., Uusitalo U., Yang J., Virtanen S. M., Liu E., Lernmark Å., Norris J. M., Agardh D.; TEDDY Study Group: Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort. Clin Gastroenterol Hepatol. 2016; 14(3):403-409.e3. IF 7.398.
  14. Uusitalo U., Liu X., Yang J., Aronsson C. A., Hummel S., Butterworth M., Lernmark Å., Rewers M., Hagopian W., She J. X., Simell O., Toppari J., Ziegler A.-G., Akolkar B., Krischer J., Norris J. M., Virtanen S. M.; TEDDY Study Group: Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study. JAMA Pediatr. 2016; 170(1):20-8. ‎IF 10.251.
  15. Lernmark B., Lynch K., Baxter J., Roth R., Simell T., Smith L., Swartling U., Johnson S. B.; Teddy Study Group: Participant Experiences in the Environmental Determinants of Diabetes in the Young Study: Common Reasons for Withdrawing. J Diabetes Res. 2016; 2016:2720650. IF 2.717.
  16. Haghighi M., Johnson S. B., Qian X., Lynch K. F., Vehik K., Huang S.; TEDDY Study Group: A Comparison of Rule-based Analysis with Regression Methods in Understanding the Risk Factors for Study Withdrawal in a Pediatric Study. Sci Rep. 2016; 6:30828. IF 4.259.
  17. Törn C., Liu X., Hagopian W., Lernmark Å., Simell O., Rewers M., Ziegler A.-G., Schatz D., Akolkar B., Onengut-Gumuscu S., Chen W. M., Toppari J., Mykkänen J., Ilonen J., Rich S. S., She J. X., Sharma A., Steck A., Krischer J.; TEDDY Study Group: Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study. Sci Rep. 2016; 6:27887. IF 4.259.
  18. Lundgren M., Steed L. J., Tamura R., Jonsdottir B., Gesualdo P., Crouch C., Sjöberg M., Hansson G., Hagopian W. A., Ziegler A.-G., Rewers M. J., Lernmark Å., Toppari J., She J.-X., Akolkar B., Krischer J. P., Haller M. J., Elding Larsson H.; TEDDY Study Group: Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity. BMC Pediatr. 2017; 17(1):127. IF 2.042.
  19. Norris J. M., Lee H.-S., Frederiksen B., Erlund I., Uusitalo U., Yang J., Lernmark Å., Simell O., Toppari J., Rewers M., Ziegler A.-G., She J.-X., Onengut-Gumuscu S., Chen W. M., Rich S. S., Sundvall J., Akolkar B., Krischer J., Virtanen S. M., Hagopian W.; TEDDY Study Group: Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity. Diabetes 2018; 67(1):146-154. IF 7.199.
  20. Uusitalo U., Lee H.-S., Andrén Aronsson C., Vehik K., Yang J., Hummel S., Silvis K., Lernmark Å., Rewers M., Hagopian W., She J.-X., Simell O., Toppari J., Ziegler A.-G., Akolkar B., Krischer J., Virtanen S. M., Norris J. M.; TEDDY Study Group: Early Infant Diet and Islet Autoimmunity in the TEDDY Study. Diabetes Care 2018; 41(3):522-530. IF 15.270.
  21. Stanfill B. A., Nakayasu E. S., Bramer L. M., Thompson A. M., Ansong C. K., Clauss T. R., Gritsenko M. A., Monroe M. E., Moore R. J., Orton D. J., Piehowski P. D., Schepmoes A. A., Smith R. D., Webb-Robertson B. M., Metz T. O.; TEDDY Study Group: Quality Control Analysis in Real-time (QC-ART): A Tool for Real-time Quality Control Assessment of Mass Spectrometry-based Proteomics Data. Mol Cell Proteomics 2018; 17(9):1824-1836. IF 4.828.
  22. Salami F., Lee H.-S., Freyhult E., Larsson H. E., Lernmark Å., Törn C.; TEDDY study Group: Reduction in White Blood Cell, Neutrophil and Red Blood Cell counts Related to Gender, HLA and Islet Autoantibodies in Swedish TEDDY Children at Increased Risk for Type 1 Diabetes. Diabetes 2018; 67(11):2329-233. IF 7.199.
  23. Rewers M., Hyöty H., Lernmark Å., Hagopian W., She J.-X., Schatz D., Ziegler A.-G., Toppari J., Akolkar B., Krischer J.; TEDDY Study Group: The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update. Curr Diab Rep. 2018; 18(12):136. IF 3.996.
  24. Endesfelder D., Zu Castell W., Bonifacio E., Rewers M., Hagopian W. A., She J.-X., Lernmark Å., Toppari J., Vehik K., Williams A. J. K., Yu L., Akolkar B., Krischer J. P., Ziegler A.-G., Achenbach P.; TEDDY Study Group: Time-Resolved Autoantibody Profiling Facilitates Stratification of Preclinical Type 1 Diabetes in Children. Diabetes 2019; 68(1):119-130. IF 7.199.
  25. Frank N. M., Lynch K. F., Uusitalo U., Yang J., Lönnrot M., Virtanen S. M., Hyöty H., Norris J. M.; TEDDY Study Group: The relationship between breastfeeding and reported respiratory and gastrointestinal infection rates in young children. BMC Pediatr. 2019 Sep 18;19(1):339. IF 1.983.

Ohne Peer-Review:

  1. Beyerlein A.: Entwicklung des Verarbeitenden Gewerbes in Bayern im Jahr 2010. Bayern in Zahlen 6/2011.
  2. Beyerlein A.: Die wirtschaftliche Entwicklung in der Kfz-Branche und im Maschinenbau in Bayern im Jahr 2010. Bayern in Zahlen 8/2011.
  3. Beyerlein A., Ziegler A.-G., Hummel S.: Diabetes bei Kindern – Erhöhen frühkindliche Umweltfaktoren das Risiko? Current Congress – Diabetes Kongress 2016.
  4. Much D., Köhler M., Beyerlein A., Ziegler A.-G., Hummel S.: Gestationsdiabetes postpartal – Typ-2-Diabetes-Risikoabschätzung und präventive Therapie. Diabetes aktuell 2016; 13(4):168–173.
  5. Beyerlein A., Jolink M.: Bewertung des Fr1da-Screenings aus epidemiologischer Sicht. Der Diabetologe 2018; 14:221-223.
  6. Gleich S., Beyerlein A., Schmidt S., Koncz V.: Impfdurchbrüche nach Impfung mit dem mRNA-Impfstoff Comirnaty (BioNTech) in Münchner Pflegeeinrichtungen Epid Bull 2021; 50:23-35.